MYC and breast cancer: Watson et al. developed a thiophosphate asON which demonstrated a more prolonged (up to 9 days) and effective (75%) inhibition of breast cancer cells proliferation and caused a 95% inhibition of estrogene-induced overexpression of c-myc gene [171].